{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T22:16:04Z","timestamp":1792880164782,"version":"4.5.0"},"reference-count":50,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2013,12,1]],"date-time":"2013-12-01T00:00:00Z","timestamp":1385856000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,4,14]],"date-time":"2016-04-14T00:00:00Z","timestamp":1460592000000},"content-version":"vor","delay-in-days":865,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Indian Heart Journal"],"published-print":{"date-parts":[[2013,12]]},"DOI":"10.1016\/j.ihj.2013.11.001","type":"journal-article","created":{"date-parts":[[2014,1,7]],"date-time":"2014-01-07T05:21:19Z","timestamp":1389072079000},"page":"691-695","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":69,"title":["The fourth-generation Calcium channel blocker: Cilnidipine"],"prefix":"10.1016","volume":"65","author":[{"given":"K. Sarat","family":"Chandra","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Ramesh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ihj.2013.11.001_bib1","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1353\/pbm.1967.0031","article-title":"The mosaic theory of arterial hypertension\u2013its interpretation","volume":"10","author":"Page","year":"1967","journal-title":"Perspect Biol Med"},{"key":"10.1016\/j.ihj.2013.11.001_bib2","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1097\/00004872-198812040-00002","article-title":"The first Irvine H. Page lecture. The mosaic of hypertension: past, present & future","volume":"6","author":"Frolich","year":"1988","journal-title":"J Hypertens Suppl"},{"key":"10.1016\/j.ihj.2013.11.001_bib3","doi-asserted-by":"crossref","first-page":"709","DOI":"10.7326\/0003-4819-98-5-709","article-title":"Mechanisms contributing to high blood pressure","volume":"98","author":"Frolich","year":"1983","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ihj.2013.11.001_bib4","first-page":"614","article-title":"Hypertension","volume":"104","author":"Chatzikyrkoyu","year":"2009","journal-title":"Med Klin(Munich)"},{"key":"10.1016\/j.ihj.2013.11.001_bib5","series-title":"Using Calcium Channel Blockers to Treat High Blood Pressure and Heart Diseases","first-page":"01","year":"2011"},{"key":"10.1016\/j.ihj.2013.11.001_bib6","doi-asserted-by":"crossref","first-page":"2560","DOI":"10.1001\/jama.289.19.2560","article-title":"The seventh report of the Joint National Committee on prevention, detection, evaluation & treatment of high blood pressure: the JNC 7 report","volume":"289","author":"Chobanian","year":"2003","journal-title":"JAMA"},{"key":"10.1016\/j.ihj.2013.11.001_bib7","doi-asserted-by":"crossref","first-page":"S121","DOI":"10.1097\/00005344-198800120-00017","article-title":"Sympathetic hyperactivity in early stages of hypertension: the Ann Arbor data set","volume":"12","author":"Julius","year":"1988","journal-title":"J Cardiovasc Pharmacol"},{"key":"10.1016\/j.ihj.2013.11.001_bib8","first-page":"5","article-title":"Calcium channel blockers: differences between subclasses","volume":"7","author":"Weir","year":"2007","journal-title":"Am J Cardiovasc Drugs"},{"key":"10.1016\/j.ihj.2013.11.001_bib9","doi-asserted-by":"crossref","first-page":"17","DOI":"10.2165\/00129784-200707001-00003","article-title":"Calcium channel blockers: differences between subclasses","volume":"7","author":"Frishman","year":"2007","journal-title":"Am J Cardiovasc Drugs"},{"key":"10.1016\/j.ihj.2013.11.001_bib10","first-page":"333","article-title":"Dihydropyridines from the first to fourth generation: better effects and safety","volume":"58","author":"Aoum","year":"2003","journal-title":"Therapie"},{"key":"10.1016\/j.ihj.2013.11.001_bib11","doi-asserted-by":"crossref","first-page":"109S","DOI":"10.1111\/j.1365-2125.1986.tb02860.x","article-title":"The mechanism of action of calcium antagonists relative to their clinical applications","volume":"21","author":"Singh","year":"1986","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.ihj.2013.11.001_bib12","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/S0031-6997(25)00463-6","article-title":"Classification of calcium channels & the sites of action of drugs modifying channel function","volume":"44","author":"Spedding","year":"1992","journal-title":"Pharmacol Rev"},{"key":"10.1016\/j.ihj.2013.11.001_bib13","doi-asserted-by":"crossref","first-page":"206","DOI":"10.3109\/08037059609079672","article-title":"Third generation calcium entry blockers","volume":"5","author":"Toyooka","year":"1996","journal-title":"Blood Press"},{"key":"10.1016\/j.ihj.2013.11.001_bib14","doi-asserted-by":"crossref","first-page":"103","DOI":"10.2174\/157340206776877370","article-title":"New generation calcium channel blockers in hypertensive treatment","volume":"2","author":"Ozawa","year":"2006","journal-title":"Curr Hypertens Rev"},{"key":"10.1016\/j.ihj.2013.11.001_bib15","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/S0896-6273(00)81057-0","article-title":"Nomenclature of voltage gated calcium channels","volume":"25","author":"Ertel","year":"2000","journal-title":"Neuron"},{"key":"10.1016\/j.ihj.2013.11.001_bib16","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1146\/annurev.pa.35.040195.003423","article-title":"Antagonists of neuronal calcium channels: structure, function & therapeutic implications","volume":"35","author":"Miljanich","year":"1995","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"10.1016\/j.ihj.2013.11.001_bib17","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/BFb0033648","article-title":"Voltage dependent calcium channels: from structure to function","volume":"139","author":"Hofmann","year":"1999","journal-title":"Rev Physiol Biochem Pharmacol"},{"key":"10.1016\/j.ihj.2013.11.001_bib18","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1016\/S0022-3565(24)36515-2","article-title":"Effect of cilnidipine, a novel dihydropyridine calcium channel antagonist, on N type calcium channel in rat dorsal root ganglion neurons","volume":"280","author":"Fujii","year":"1997","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.ihj.2013.11.001_bib19","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1038\/sj.bjp.0701342","article-title":"Blockade of N type calcium current by cilnidipine (FRC 8653) in acutely dissociated rat sympathetic neurones","volume":"122","author":"Uneyama","year":"1997","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.ihj.2013.11.001_bib20","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S0014-2999(99)00237-X","article-title":"Selectivity of dihydropyridines for cardiac L type & sympathetic N type calcium channels","volume":"373","author":"Uneyama","year":"1999","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.ihj.2013.11.001_bib21","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1291\/hypres.26.743","article-title":"Neuronal calcium channel blocking action of antihypertensive drug, cilnidipine in IMR-32 human neuroblastoma cells","volume":"26","author":"Takahara","year":"2003","journal-title":"Hypertens Res"},{"key":"10.1016\/j.ihj.2013.11.001_bib22","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1111\/j.1472-8206.2004.00236.x","article-title":"The evaluation of N type channel blocking properties of cilnidipine and other voltage dependent calcium antagonists","volume":"18","author":"Nap","year":"2004","journal-title":"Fundam Clin Pharmacol"},{"key":"10.1016\/j.ihj.2013.11.001_bib23","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1254\/jjp.69.127","article-title":"Inhibitory effect of cilnidipine on vascular sympathetic neurotransmission & subsequent vasoconstriction in spontaneously hypertensive rats","volume":"69","author":"Hosono","year":"1995","journal-title":"Jpn J Pharmacol"},{"key":"10.1016\/j.ihj.2013.11.001_bib24","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S0014-2999(01)01521-7","article-title":"Antisympathetic & hemodynamic property of a dual L\/N type calcium channel blocker cilnidipine in rats","volume":"434","author":"Takahara","year":"2002","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.ihj.2013.11.001_bib25","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1097\/00005344-199809000-00020","article-title":"Effect of cilnidipine, a novel dihydropyridine calcium channel blocker, on adrenal catecholamine secretion in anesthetized dogs","volume":"32","author":"Nagayama","year":"1998","journal-title":"J Cardiovasc Pharmacol"},{"key":"10.1016\/j.ihj.2013.11.001_bib26","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1291\/hypres.28.361","article-title":"Cilnidipine, an N+L type dihydropyridine calcium channel blocker, suppress the occurrence of ischemia\/reperfusion arrhythmia in rabbit model of myocardial infarction","volume":"28","author":"Nagai","year":"2005","journal-title":"Hypertens Res"},{"key":"10.1016\/j.ihj.2013.11.001_bib27","first-page":"575","article-title":"Long term blockade of N type calcium channels reversed the ventricular electrical remodelling in the canine model of long QT syndrome","volume":"70","author":"Takahara","year":"2006","journal-title":"Circ J"},{"key":"10.1016\/j.ihj.2013.11.001_bib28","article-title":"Antianginal effects of L type N type calcium channel blocker cilnidipine assessed using vasopressin induced experimental angina model in rats","volume":"91","author":"Saitoh","year":"2003","journal-title":"J Pharmacol Sci"},{"key":"10.1016\/j.ihj.2013.11.001_bib29","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1291\/hypres.30.815","article-title":"The effect of combination therapy with L\/N type calcium channel blocker cilnidipine, & an angiotensin II receptor blocker on blood pressure & heart rate in Japanese hypertensive patients: an observational study conducted in Japan","volume":"30","author":"Nagahama","year":"2007","journal-title":"Hypertens Res"},{"key":"10.1016\/j.ihj.2013.11.001_bib30","first-page":"S155","article-title":"Study of FRC-8653 (cilnidipine) in patients with severe hypertension","volume":"21","author":"Iimura","year":"1993","journal-title":"Jpn Pharmacol Ther"},{"key":"10.1016\/j.ihj.2013.11.001_bib31","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1291\/hypres.28.1003","article-title":"Comparison of the effects of cilnidipine and amlodipine on ambulatory blood pressure","volume":"28","author":"Hoshide","year":"2005","journal-title":"Hypertens Res"},{"key":"10.1016\/j.ihj.2013.11.001_bib32","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1536\/ihj.48.597","article-title":"Bedtime administration of cilnidipine controls morning hypertension","volume":"48","author":"Ashizawa","year":"2007","journal-title":"Int Heart J"},{"key":"10.1016\/j.ihj.2013.11.001_bib33","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1291\/hypres.29.339","article-title":"Beneficial effect of cilnidipine on morning hypertension & white coat effect in patients with essential hypertension","volume":"29","author":"Yamagishi","year":"2006","journal-title":"Hypertens Res"},{"key":"10.1016\/j.ihj.2013.11.001_bib34","first-page":"459","article-title":"Effects of cilnidipine versus atenolol on left ventricular diastolic function and hypertrophy in essential hypertension \u2013 CANDLE trial","volume":"26","author":"Chung","year":"2008","journal-title":"J Hypertens"},{"key":"10.1016\/j.ihj.2013.11.001_bib35","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1097\/FJC.0b013e31802bfdee","article-title":"Cilnidipine improves left ventricular midwall function independently of blood pressure changes in Chinese patients with hypertension","volume":"49","author":"Ma","year":"2007","journal-title":"J Cardiovasc Pharmacol"},{"key":"10.1016\/j.ihj.2013.11.001_bib36","doi-asserted-by":"crossref","first-page":"2677","DOI":"10.1001\/jama.287.20.2677","article-title":"Pulse pressure & cardiovascular disease related mortality: follow up study of the multiple risk factor intervention trial (MRFIT)","volume":"287","author":"Domanski","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.ihj.2013.11.001_bib37","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1161\/01.HYP.0000101695.56635.31","article-title":"Effect of blood pressure on early decline in kidney function among hypertensive men","volume":"42","author":"Vupputuri","year":"2003","journal-title":"Hypertension"},{"key":"10.1016\/j.ihj.2013.11.001_bib38","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1056\/NEJM199601043340103","article-title":"Blood pressure and end stage disease in men","volume":"334","author":"Klag","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ihj.2013.11.001_bib39","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0735-1097(02)02663-3","article-title":"Level of kidney function as a risk factor for atherosclerotic cardiovascular outcomes in the community","volume":"41","author":"Manjunath","year":"2003","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ihj.2013.11.001_bib40","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1161\/01.CIR.0000031732.78052.81","article-title":"Urinary albumin excretion predicts cardiovascular & non cardiovascular mortality in general population","volume":"106","author":"Hillege","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.ihj.2013.11.001_bib41","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1291\/hypres.24.377","article-title":"Cilnidipine as effective as benazepril for control of blood pressure and proteinuria in hypertensive patients with benign nephrosclerosis","volume":"24","author":"Rose","year":"2001","journal-title":"Hypertens Res"},{"key":"10.1016\/j.ihj.2013.11.001_bib42","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1291\/hypres.27.379","article-title":"Comparison between cilnidipine and amlodipine besilate with respect to proteinuria in hypertensive patients with renal diseases","volume":"27","author":"Kojima","year":"2004","journal-title":"Hypertens Res"},{"key":"10.1016\/j.ihj.2013.11.001_bib43","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1080\/10641960500298558","article-title":"Antiproteinuric effect of N type calcium channel blocker, cilnidipine","volume":"27","author":"Tsuchihashi","year":"2005","journal-title":"Clin Exp Hypertens"},{"key":"10.1016\/j.ihj.2013.11.001_bib44","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1038\/sj.ki.5000349","article-title":"Comparison between valsartan and valsartan plus cilnidipine in type II diabetics with normo- and microalbuminuria","volume":"70","author":"Katayama","year":"2006","journal-title":"Kidney Int"},{"key":"10.1016\/j.ihj.2013.11.001_bib45","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1038\/sj.ki.5002623","volume":"72","author":"Fujita","year":"2007","journal-title":"Kidney Int"},{"key":"10.1016\/j.ihj.2013.11.001_bib46","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1056\/NEJMoa041031","article-title":"Chronic kidney disease and risks of death, cardiovascular events and hospitalization","volume":"351","author":"Go","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ihj.2013.11.001_bib47","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1111\/j.1755-5922.2009.00126.x","article-title":"Beneficial effects of L & N type calcium channel blocker on glucose and lipid metabolism & renal function in patients with hypertension and type II diabetes mellitus","volume":"29","author":"Takashi","year":"2011","journal-title":"Cardiovasc Ther"},{"key":"10.1016\/j.ihj.2013.11.001_bib48","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1016\/j.jtcvs.2010.01.048","article-title":"Dual actions of cilnidipine in human internal thoracic artery: inhibition of calcium channel & enhancement of endothelial nitric oxide synthase","volume":"141","author":"Fan","year":"2011","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.ihj.2013.11.001_bib49","doi-asserted-by":"crossref","first-page":"47","DOI":"10.4103\/1947-2714.106203","article-title":"Excellent tolerance to cilnidipine in hypertensives with amlodipine induced edema","volume":"5","author":"Shetty","year":"2013","journal-title":"N Am J Med Sci"},{"key":"10.1016\/j.ihj.2013.11.001_bib50","first-page":"2393","article-title":"A meta analysis of the efficacy & safety of cilnidipine in Chinese patients with mild to moderate essential hypertension","volume":"6","author":"Guo-Liang","year":"2012","journal-title":"Afr J Pharm Pharmacol"}],"container-title":["Indian Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0019483213003386?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0019483213003386?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T11:28:51Z","timestamp":1746098931000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0019483213003386"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,12]]},"references-count":50,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["S0019483213003386"],"URL":"https:\/\/doi.org\/10.1016\/j.ihj.2013.11.001","relation":{},"ISSN":["0019-4832"],"issn-type":[{"value":"0019-4832","type":"print"}],"subject":[],"published":{"date-parts":[[2013,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The fourth-generation Calcium channel blocker: Cilnidipine","name":"articletitle","label":"Article Title"},{"value":"Indian Heart Journal","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ihj.2013.11.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Published by Elsevier, a division of Reed Elsevier India, Pvt. Ltd.","name":"copyright","label":"Copyright"}]}}